StockWatch
·
 Medicinal Chemicals and Botanical Products
AuditorMay 15, 2026, 05:13 PM

Canopy Growth to Restate Financials Due to Accounting Error

AI Summary

Canopy Growth Corporation announced that its previously issued financial statements for fiscal years ended March 31, 2024 and 2025, and eight interim quarterly periods, should no longer be relied upon. This is due to a non-cash technical accounting error where certain share-settled warrants were incorrectly classified as equity instead of liabilities. The company plans to restate these financials in its Annual Report on Form 10-K for the fiscal year ended March 31, 2026, expected to be filed on June 15, 2026. The restatement is not expected to impact revenue, gross margin, operating income/loss, cash flows, or liquidity, but management anticipates reporting a material weakness in internal control over financial reporting.

Key Highlights

  • Canopy Growth will restate audited consolidated financial statements for fiscal years ended March 31, 2024 and 2025.
  • Unaudited consolidated financial statements for 8 quarterly periods from Sep 30, 2023 to Dec 31, 2025 will also be restated.
  • The error involves classifying share-settled warrants as equity instead of liabilities due to Canadian dollar functional currency.
  • The restatement is expected to be non-cash, reclassifying between equity and liabilities, with fair value adjustments.
  • No impact is expected on revenue, gross margin, operating income/loss, cash flows, Adjusted EBITDA, total assets, or debt covenants.
  • Management expects to report a material weakness in internal control over financial reporting.
  • Restated financials and FY2026 results are expected to be filed on June 15, 2026.
  • The company has applied for a voluntary management cease trade order (MCTO) for certain directors and officers.